Invention Grant
- Patent Title: Polyethlene glycol modifications of thymosin alpha-1
- Patent Title (中): 胸腺素α-1的聚乙二醇修饰
-
Application No.: US12093240Application Date: 2006-11-11
-
Publication No.: US08080522B2Publication Date: 2011-12-20
- Inventor: Keliang Liu , Jiankun Qie , Jinbo Ma , Jianquan Zheng , Sijian Dong , Wenxia Zhou , Chunhui Qi
- Applicant: Keliang Liu , Jiankun Qie , Jinbo Ma , Jianquan Zheng , Sijian Dong , Wenxia Zhou , Chunhui Qi
- Applicant Address: CN Beijing
- Assignee: Institute of Pharmacology and Toxicology Academy of Military Mecical Sciences, P.L.A., China
- Current Assignee: Institute of Pharmacology and Toxicology Academy of Military Mecical Sciences, P.L.A., China
- Current Assignee Address: CN Beijing
- Agency: Alston & Bird LLP
- Priority: CN200510117752 20051110
- International Application: PCT/CN2006/003021 WO 20061111
- International Announcement: WO2007/054030 WO 20070518
- Main IPC: C07K14/575
- IPC: C07K14/575 ; A61K38/22
Abstract:
Polyethylene glycol modifications of thymosin alpha 1 (T&agr; 1-PEGs), their preparation process, the medicine composition containing them, and their application in the medicine for preventing and treating diseases related with immune deficiency and hypoimmunity, including hepatitis B, hepatitis C, hepatoma, malignant melanoma, non-small cell lung cancer, SARS, and AIDS etc.
Public/Granted literature
- US20090221487A1 POLYETHLENE GLYCOL MODIFICATIONS OF THYMOSIN ALPHA-1 Public/Granted day:2009-09-03
Information query
